"TBSF" (20%) Human Albumin Solution

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

Albumin, Quantity: 200 g/L

متاح من:

CSL Behring Australia Pty Ltd

INN (الاسم الدولي):

Albumin

الشكل الصيدلاني:

Injection, solution

تركيب:

Excipient Ingredients: octanoate; sodium

طريقة التعاطي:

Intravenous

الوحدات في الحزمة:

50mL, 100mL

الفئة:

Medicine Listed (Export Only)

نوع الوصفة الطبية :

(S1) This Schedule is intentionally blank

الخصائص العلاجية:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

ملخص المنتج:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

الوضع إذن:

Listed (Export Only)

تاريخ الترخيص:

2006-03-01